Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway

被引:105
作者
Feng, WJ
Webb, P
Nguyen, P
Liu, XH
Li, JD
Karin, M
Kushner, PJ [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit 1119 HSW, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1210/me.15.1.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect 88 activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these coactivators, which are known to mediate AF-1 action.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 88 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   MODULATION OF TRANSCRIPTIONAL ACTIVATION BY LIGAND-DEPENDENT PHOSPHORYLATION OF THE HUMAN ESTROGEN RECEPTOR-A/B REGION [J].
ALI, S ;
METZGER, D ;
BORNERT, JM ;
CHAMBON, P .
EMBO JOURNAL, 1993, 12 (03) :1153-1160
[3]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[4]   Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation [J].
Arnold, SF ;
Melamed, M ;
Vorojeikina, DP ;
Notides, AC ;
Sasson, S .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (01) :48-53
[5]  
ARNOLD SF, 1995, J BIOL CHEM, V270, P30205
[6]  
AURICCHIO F, 1995, CELL GROWTH DIFFER, V6, P105
[7]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[8]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[9]   ESTRADIOL MEMBRANE-BINDING SITES ON HUMAN-BREAST CANCER CELL-LINES - USE OF A FLUORESCENT ESTRADIOL CONJUGATE TO DEMONSTRATE PLASMA-MEMBRANE BINDING SYSTEMS [J].
BERTHOIS, Y ;
POURREAUSCHNEIDER, N ;
GANDILHON, P ;
MITTRE, H ;
TUBIANA, N ;
MARTIN, PM .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (06) :963-972
[10]   L-selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac [J].
Brenner, B ;
Weinmann, S ;
Grassme, H ;
Lang, F ;
Linderkamp, O ;
Gulbins, E .
IMMUNOLOGY, 1997, 92 (02) :214-219